Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Bayer : Middle East announces partnership with the United Nations Population Fund Egypt, to support the Ministry of Health and Population's ‘Your Right to Plan' campaign in Egypt on World Contraception Day

09/26/2021 | 02:12am EDT
Sunday - September 26, 2021
Bayer Middle East and UNFPA Egypt highlight the importance of providing accessible family planning and reproductive health services to Egyptian families:
Bayer Middle East announces partnership with the United Nations Population Fund Egypt, to support the Ministry of Health and Population's 'Your Right to Plan' campaign in Egypt on World Contraception Day
The 'Your Right to Plan' campaign aims at improving family planning and reproductive health services to Egypt's underserved communities / The five-year partnership involves a total donation of EUR 330,000 / The program provides access to medical services in relation to family planning, such as OB-GYN examinations, ultrasound diagnosis, and pediatric services

Egypt, September 27, 2021 - Bayer Middle East has announced the launch of a strategic five-year family planning partnership with the United Nations Population Fund in Egypt to support the Ministry of Health and Population's campaign entitled 'Your Right to Plan'. The campaign promotes rights-based approach to family planning and offers free family planning services. Furthermore, the campaign aims to provide access to family planning and reproductive health services, to raise community awareness and increase demand for family planning services to Egypt's underserved communities.

The event took place on September 27 at the Cairo Marriott Hotel, on World Contraception Day. The event brought together key stakeholders such as H.E. Mr. Frank Hartmann, Ambassador of the Federal Republic of Germany to the Arab Republic of Egypt, Dr. Hossam Abbas Elgalad, Head of Family Planning Sector at the Ministry of Health & Population and Dr. Ahmed El Minawi, Professor of Obstetrics & Gynecology, Cairo University & Director of the Virtual Endoscopic Simulation and Skills Acquisition, marking the commencement of the five-year strategic partnership between Bayer Middle East and the UNFPA Egypt.

The 'Your Right to Plan' campaign is a comprehensive program developed by the Ministry of Health Family Planning Sector, in collaboration with UNFPA and previously supported by the European Union in Egypt, to provide resources to underserved communities concerning reproductive health and FP services in Egypt. Bayer Middle East has pledged to co-fund the program with a total donation of EUR 330,000, with EUR 50,000 to be given in 2021 and EUR 70,000 each year from 2022 until 2025.

Egypt's population has reached 102,170,000 people, with one birth happening every 14 seconds - the eighth highest birth rate in the world. That is four births a minute, or 255 births every hour, or 6,000 births a day. Without any further targeted interventions, the population can rise to to 160 million by 2050, against the current trend as per CAPMAS latest report. As Egypt witnesses this very rapid growth in its population, immense pressure on the domestic economy and healthcare system could occur.

For 50 years now, Bayer has been working with a network of public and private partners to enable women and girls to assert their right to self-determined family planning worldwide. Family Planning is an important step toward breaking the cycle of poverty - both for women and their families and for the countries where they live lies at the heart of sustainable development. Improving people's quality of life, investing in education, securing resources for the entire population, protecting the environment, can be achieved through a targeted and dynamic FP initiative.

Through this joint effort, UNFPA and Bayer aim to reach a total of 200,000 women with modern contraceptives as well as 300,000 women with access to essential educational reproductive health awareness messages and services. The campaign will support target groups by providing access to vital reproductive health services such as OB-GYN examinations, ultrasound diagnosis, antenatal care, and pediatric and newborn services. Community-based distribution campaigns via mobile clinics will be held to increase access and use of FP services, particularly in the under-served rural areas.

Another main activity of the campaign includes holding awareness-raising seminars for women of reproductive age in Egypt, to emphasize the importance of FP and benefits of small families. This will target their spouses, to ensure male engagement and support to family planning, as well as mothers in law and mothers, who are believed to influence the FP behavior of married couples in Egypt.

Commenting on the strategic partnership, Frederika Meijer, Country Representative UNFPA Egypt Country Office, said, "Our partnership with Bayer Middle East is directed to the "Your Right to Plan" campaign. The contribution aims at reaching underserved areas, Access to FP services is central to achieving gender equality. When women and couples have the information and services to plan whether and when they want to have children, then a woman's autonomy within the household is increased, her likelihood of staying in the workforce is increased and her overall earnings are improved. This strengthens both her economic security and well-being and that of her family. This initiative will therefore greatly contribute to the Governments' aim to stabilize population growth with Egypt's economy. It focusses on those who are most difficult to reach and is in line with UNFPA's strategic vision of reaching ZERO unmet need for family Planning."

Samer Lezzaiq, Managing Director and Commercial Area Head Pharmaceuticals Division - Egypt, added, "We are constantly working to fulfill our vision here at Bayer, which is 'Health for All, Hunger for None'. We are very pleased to join forces with capable UN Organisations such as the UNFPA who share our values and materialize this aim as we all work on promoting access to health resources and services, raising standards, and supporting reproductive health awareness in our core communities, one of which is Egypt."

"This campaign in particular supports our sustainability targets to provide 100 million women in underserved communities with access to modern contraception which is in syncronization with the United Nation's Sustainable Development Goals 3 on Good health and Well being. Moreover, our engagement is fully in line with Bayer's strategic charitable giving approach aimed at long-term change and societal progress," stated Sami Joost, Head of Communications / Public Affairs, Science & Sustainability (PASS) - Middle East.

###

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.

About UNFPA
UNFPA is the lead UN agency for delivering a world where every pregnancy is wanted, every childbirth is safe and every young person's potential is fulfilled.

UNFPA started working in 1969 and now works in more than 150 countries, which are home to more than 80 percent of the world population. Its main aim is to ensure reproductive rights for all, leaving no one behind and targets the furthest behind first. Ensuring that women and young people are able to access high-quality reproductive health services, including voluntary FP, so that they can make informed and voluntary choices about their reproductive lives.

The UNFPA strategic plan, 2022-2025, was just approved in the Executive board meeting of UNFPA, UNDP and UNOPS second regular session 2021. The strategic plan focuses on acceleration progress towards the achievement of the three transformative results: (a) ending unmet need for FP and modern contraceptives; (b) ending preventable maternal deaths; and (c) ending gender-based violence and harmful practices, such as child marriage and female genital mutilation.

The current progress towards these results is not enough to achieve them by 2030. Acceleration is needed. Yet doing business as usual will not generate the needed acceleration. Hence, new ways of doing business must be adopted to adapt to the rapidly changing environment and leverage emerging opportunities to pursue solutions that lead to sustainable development while leaving no one behind.

This PRL is being issued by Hill+Knowlton Strategies on behalf of Bayer, for further information please contact:
Kholoud El Sharkawy
Account Director, Hill + Knowlton Strategies
Email: kholoud.elsharkawy@hkstrategies.com
Telephone: +971 2 447 2805

Sami Joost
Head of Communications / Public Affairs, Science & Sustainability (PASS) - Middle East
Email: sami.joost@bayer.com

For Medical Information: med-info.me@bayer.com
For Safety Reporting: pv.me@bayer.com

Assya ElShokeiry
Communications Specialist
UNFPA Egypt Country Office
Email: elshokeiry@unfpa.org

Find more information at egypt.unfpa.org
Find more information at www.bayer.com.

A version in Arabic is available here

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or development

Disclaimer

Bayer AG published this content on 26 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 September 2021 06:11:02 UTC.


ę Publicnow 2021
All news about BAYER AG
08:08aBayer to present new data from comprehensive finerenone clinical trial program
PU
07:00aPRESS RELEASE : BioNTech to Report Third Quarter Financial Results and Operational Update ..
DJ
10/26PRESS RELEASE : FDA Advisory Committee Votes in -3-
DJ
10/26BAYER AG : JP Morgan reiterates its Buy rating
MD
10/26PRESS RELEASE : BioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturi..
DJ
10/26Bayer Invests $5.9 Million to Expand Spanish Vegetable Seeds R&D Facility
MT
10/25PRESS RELEASE : Linde plc: Linde Board Elects Two New Directors and Adds Sustainability Co..
DJ
10/25DOLLARS IN THE DIRT : Big Ag pays farmers for control of their soil-bound carbon
RE
10/22Mexico's agriculture minister say Mexico will not limit GMO corn imports from U.S
RE
10/22PRESS RELEASE : AiCuris announces expansion of its collaboration with Lysando with a focus..
DJ
More news
Analyst Recommendations on BAYER AG
More recommendations
Financials
Sales 2021 42 492 M 49 304 M 49 304 M
Net income 2021 864 M 1 002 M 1 002 M
Net Debt 2021 39 356 M 45 665 M 45 665 M
P/E ratio 2021 34,9x
Yield 2021 4,20%
Capitalization 47 741 M 55 326 M 55 394 M
EV / Sales 2021 2,05x
EV / Sales 2022 1,94x
Nbr of Employees 99 439
Free-Float 100,0%
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 48,60 €
Average target price 61,36 €
Spread / Average Target 26,3%
EPS Revisions
Managers and Directors
Werner Baumann Chairman-Management Board & CEO
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BAYER AG1.32%55 574
JOHNSON & JOHNSON5.32%436 334
ROCHE HOLDING AG15.84%338 387
NOVO NORDISK A/S60.69%244 467
PFIZER, INC.17.22%244 227
ELI LILLY AND COMPANY47.15%225 231